Fibrinogen alpha C chain 5.9 kDa fragment (FIC5.9), a biomarker for various pathological conditions, is produced in post-blood collection by fibrinolysis and coagulation factors
Open Access
- 7 October 2016
- journal article
- research article
- Published by Springer Nature in Clinical Proteomics
- Vol. 13 (1) , 1-7
Abstract
Fibrinogen alpha C chain 5.9 kDa fragment (FIC5.9) is a new serum biomarker for chronic hepatitis that was discovered by proteomics analysis. Previous studies have shown that FIC5.9 is derived from the C-terminal region of fibrinogen alpha chain and the serum levels of FIC5.9 decrease in chronic hepatitis. It also have been reported that FIC5.9 cannot be detected in the blood stream of the systemic circulation and it is released from fibrinogen during blood clotting in collecting tube. However, the mechanism of FIC5.9 releasing from fibrinogen is unclear. We formulated a hypothesis that FIC5.9 is released by enzymes that are activated by post-blood collection and may be coagulation and fibrinolysis factors. In this study, we analyzed the mechanisms of FIC5.9 releasing from fibrinogen in healthy blood. Our analysis showed that thrombin acts as an initiator for FIC5.9 releasing, and that mainly plasmin cleaves N-terminal end of FIC5.9 and neutrophil elastase cleave C-terminal end of FIC5.9. FIC5.9 reflects minute changes in coagulation and fibrinolysis factors and may be associated with pathological conditions.Keywords
This publication has 40 references indexed in Scilit:
- Biological Significance of Local TGF-β Activation in Liver DiseasesFrontiers in Physiology, 2012
- Macrophage Phenotype Modulation by CXCL4 in AtherosclerosisFrontiers in Physiology, 2012
- Leptospiral Endostatin-Like Protein A Is a Bacterial Cell Surface Receptor for Human PlasminogenInfection and Immunity, 2010
- Tipifarnib Plus Tamoxifen in Tamoxifen-Resistant Metastatic Breast Cancer: A Negative Phase II and Screening of Potential Therapeutic Markers by Proteomic AnalysisClinical Cancer Research, 2010
- What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schemaScandinavian Journal of Clinical and Laboratory Investigation, 2010
- Role of neutrophil elastase in LTB4‐induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient miceBritish Journal of Pharmacology, 2007
- Thrombin generation and fibrin clot structureBlood Reviews, 2007
- Coagulation Disorders in Liver DiseaseSeminars in Liver Disease, 2002
- Differential autolysis of human and canine plasminsBiochemical and Biophysical Research Communications, 1980
- Coagulation Studies in Patients with Acute Infectious HepatitisBritish Journal of Haematology, 1972